NAD+ — 500mg
249.99€
The multi-peptide metabolic repair stack plus KPV, the tripeptide NF-kB inhibitor that adds targeted inflammatory control to tissue regeneration.
279.99€
Netto 279.99€
Wyłącznie do badań laboratoryjnych. Nie do stosowania u ludzi ani zwierząt.
KLOW is a proprietary multi-peptide blend formulated for metabolic optimization and body composition research. Combining synergistic peptide compounds at research-relevant doses, KLOW was designed for investigators studying multi-pathway approaches to metabolic function. The 80mg formulation provides a higher peptide payload for sustained research protocols.
KLOW is a proprietary multi-peptide blend formulated for metabolic optimization and body composition research. Combining synergistic peptide compounds at research-relevant doses, KLOW was designed for investigators studying multi-pathway approaches to metabolic function. The 80mg formulation provides a higher peptide payload for sustained research protocols.
KLOW is a proprietary multi-peptide blend containing: - Copper tripeptide complex, modulates 4,000+ genes, drives collagen synthesis, tissue remodeling, and copper delivery for antioxidant enzymes - Gastric pentadecapeptide, promotes angiogenesis, NO modulation, growth factor upregulation - Thymosin Beta-4 fragment, actin regulation, systemic cell migration and tissue repair - Alpha-MSH C-terminal tripeptide, potent anti-inflammatory via NF-kB inhibition and PepT1-mediated intestinal uptake The blend targets complementary repair pathways: BPC-157 (local repair signaling), TB-500 (systemic cell migration), GHK-Cu (tissue remodeling and gene expression), and KPV (inflammation control).
Poznanie mechanizmu: Individual components well-characterized; four complementary pathways (repair, migration, remodeling, anti-inflammatory)
No blend-specific studies. Components: GHK-Cu (topical human data), BPC-157 (100s preclinical), TB-500 (preclinical), KPV (animal + in vitro) opublikowanych badań w zbiorze danych
Experimental — No research on the blend itself. Individual components range from Experimental (BPC-157, TB-500, KPV) to Emerging (GHK-Cu). The synergistic rationale is sound but unvalidated as a combination.
GHK-Cu has human cosmetic trials. KPV has animal inflammation models. BPC-157 and TB-500 preclinical only. No data on this specific 4-peptide combination.
Proszek liofilizowany: Room temp or refrigerated
Po rekonstytucji: Refrigerate, use within 28 days
Badany w kontekście: Comprehensive injury recovery, Skin rejuvenation, Chronic inflammation, Post-surgical healing, Joint and tendon repair
Zgłaszany początek działania: 1-2 weeks for tissue repair effects; ISRs from GHK-Cu immediate
Zgłaszany czas trwania: 4-8 week cycles typical
Relacje społeczności: ISRs from GHK-Cu component are the #1 complaint. Users who understand individual components appreciate the convenience. KPV addition is valued for inflammation management. "If you'd buy all four individually, the blend saves money and injection volume."
For research and educational use only. Source values are reproduced from the current PeptidesEuro content dataset and are not medical advice.
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: Systematic Review
Significant preclinical evidence for musculoskeletal healing via angiogenesis and anti-inflammatory properties. Tissue repair component of KLOW blend.
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Orally delivered KPV decreases colitis severity via NF-kB inhibition. Anti-inflammatory foundation for KLOW's inflammation management component.
Utilizing Thymosin Beta-4 to Remind Adult Organs of Their Embryonic State
Thymosin Beta-4 activates embryonic repair programs in adult tissue; promotes cardiac and tissue regeneration. Systemic repair component of KLOW blend.
Badania podano w celach informacyjnych. Większość przeprowadzono na modelach zwierzęcych lub komórkowych; ich wyniki nie dowodzą bezpieczeństwa ani działania u ludzi.
KLOW blend … added a KLOW blend at the same time … saved my hair.
Based on 1 qualifying reports from 1 threads. 31 candidates excluded as duplicates, promotion, deleted content, or lacking concrete personal experience. Reddit self-reports are not medical evidence or proof of causation.
Pytania i odpowiedzi zapisane dla tego produktu.
Reconstitute with 2mL bacteriostatic water (40mg/mL). Standard dose is 0.1-0.2mL daily (4-8mg total blend), providing ~250-500mcg each of BPC-157, TB-500, and KPV, plus 1.25-2.5mg GHK-Cu per injection. Cycle for 4-8 weeks.
KLOW is GLOW + KPV. GLOW (70mg) contains GHK-Cu, TB-500, and BPC-157 for skin and tissue repair. KLOW (80mg) adds KPV (10mg) for targeted anti-inflammatory support via NF-kB inhibition. If inflammation management is important to your research, KLOW is the upgrade.
KLOW contains GHK-Cu (50mg) for tissue remodeling and gene expression modulation, BPC-157 (10mg) for local repair signaling, TB-500 (10mg) for systemic cell migration and repair, and KPV (10mg) for NF-kB-mediated anti-inflammatory control. Total: 80mg.
Ten produkt nie ma jeszcze opinii.
Dane produktu, źródła i zamówienie pozostają ze sobą powiązane.

Wybierz związek i rozmiar fiolki w katalogu.

Otwórz szczegóły produktu i powiązane badania.

Zapisz źródła do swojej dokumentacji.
Struktura, dostępne rozmiary i uwagi dotyczące obchodzenia się w jednym miejscu.
Strony produktów prowadzą do badań dotyczących każdego związku.
Zamówienia i ich szczegóły pozostają na Twoim koncie.
Cena, dostępność i podatek przy każdym produkcie.
PeptidesEuro is a research materials supplier operated by Pepticore LLC. We provide high-purity peptides and research compounds for in-vitro laboratory and scientific research purposes. All products are sold strictly for research use only and are not intended for human or animal consumption.
No. All products sold through meimx.com are intended strictly for in-vitro laboratory and scientific research purposes only. They are not intended for human or animal consumption, injection, ingestion, inhalation, or any form of administration to living organisms. By purchasing from PeptidesEuro, you acknowledge and agree to these terms as outlined in our Terms of Service.
No. Our products have not been evaluated, approved, or authorized by the U.S. Food and Drug Administration (FDA) or any other regulatory body. They are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. PeptidesEuro is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
No. PeptidesEuro does not provide medical advice, treatment recommendations, or dosing instructions. Any information on our website, including product descriptions and referenced research, is provided for educational and informational purposes only. If you have medical questions, please consult a licensed healthcare provider.
Research Use Only means that our products are sold exclusively as reference standards and research materials for use in laboratory and scientific research settings. Purchasers agree to use all products solely for legitimate research purposes in compliance with all applicable laws and regulations.
Przeglądaj katalog albo odpowiedz na jedno pytanie w wyszukiwarce produktów.